Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...

Podrobná bibliografie
Hlavní autoři:	M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova
Médium:	Článek
Jazyk:	Russian
Vydáno:	LLC "Publishing House OKI" 2024-06-01
Edice:	Антибиотики и Химиотерапия
Témata:	influenza rheumatoid arthritis ankylosing spondylitis psoriatic arthritis vaccination efficacy immunogenicity safety
On-line přístup:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1129

Podobné jednotky

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
Autor: M. M. Baranova, a další
Vydáno: (2024-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
Autor: D. V. Bukhanova, a další
Vydáno: (2018-07-01)

Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
Autor: Alyssa Howren, a další
Vydáno: (2025-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
Autor: Matthew Carroll, a další
Vydáno: (2015-01-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
Autor: Svedbom A, a další
Vydáno: (2017-01-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
Autor: Zlatković-Švenda Mirjana, a další
Vydáno: (2022-01-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
Autor: Hermine Leroi, a další
Vydáno: (2020-05-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
Autor: I Z Gaydukova, a další
Vydáno: (2018-12-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
Autor: Takacs P, a další
Vydáno: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
Autor: Joshua L. Lee, a další
Vydáno: (2018-08-01)

The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
Autor: M. M. Baranova, a další
Vydáno: (2021-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Autor: M. Rossini, a další
Vydáno: (2015-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
Autor: Taras S. Panevin, a další
Vydáno: (2024-06-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
Autor: I. Pantano, a další
Vydáno: (2023-03-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
Autor: Milena Iwaszko, a další
Vydáno: (2021-11-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
Autor: Viola Sacchi, a další
Vydáno: (2010-06-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
Autor: Krzysztof Bonek, a další
Vydáno: (2022-04-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
Autor: Santhi Mantravadi, a další
Vydáno: (2020-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
Autor: Philip Brenner, a další
Vydáno: (2020-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
Autor: E. E. Gubar, a další
Vydáno: (2023-08-01)

Nod-like receptors in inflammatory arthritis
Autor: Sahib Singh Madahar, a další
Vydáno: (2024-02-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
Autor: Xinlin Nie, a další
Vydáno: (2023-10-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Autor: M. Elaine Husni, a další
Vydáno: (2022-03-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
Autor: Christian Dejaco, a další
Vydáno: (2022-06-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
Autor: D. V. Bukhanova, a další
Vydáno: (2018-07-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
Autor: Eleonora Alina Dragomir-Lica, a další
Vydáno: (2023-09-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
Autor: Hanna Park, a další
Vydáno: (2024-01-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
Autor: Acar M, a další
Vydáno: (2018-11-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
Autor: Yu. V. Muravyev, a další
Vydáno: (2020-05-01)

Adherence to biological therapies in patients with chronic inflammatory arthropathies
Autor: Noemí Martínez-López de Castro, a další
Vydáno: (2019-07-01)

Unraveling immune cell heterogeneity in autoimmune arthritis: insights from single-cell RNA sequencing
Autor: Sotaro Nakajima, a další
Vydáno: (2024-10-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
Autor: Andrea Picchianti-Diamanti, a další
Vydáno: (2025-02-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
Autor: Giovanni Cioffi, a další
Vydáno: (2021-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
Autor: I. Z. Gaidukova, a další
Vydáno: (2015-03-01)

Prevalence of spondyloarthritis and its subtypes - are they really comparable?
Autor: Zlatković-Švenda Mirjana I., a další
Vydáno: (2019-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
Autor: R. M. Balabanova, a další
Vydáno: (2021-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
Autor: Muhammad Haroon, a další
Vydáno: (2018-04-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
Autor: Jaroslaw Nowakowski, a další
Vydáno: (2023-10-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
Autor: Tacjana Anna Barczyńska, a další
Vydáno: (2015-12-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
Autor: T. V. Dubinina, a další
Vydáno: (2023-02-01)